{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T06:16:09Z","timestamp":1772000169210,"version":"3.50.1"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2023,10,19]],"date-time":"2023-10-19T00:00:00Z","timestamp":1697673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2023,10,19]],"date-time":"2023-10-19T00:00:00Z","timestamp":1697673600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"name":"Cure SMA Industry Collaboration"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Ther"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1007\/s40120-023-00552-y","type":"journal-article","created":{"date-parts":[[2023,10,19]],"date-time":"2023-10-19T14:02:05Z","timestamp":1697724125000},"page":"2161-2175","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Evaluating Perceived Fatigue within an Adult Spinal Muscular Atrophy Population"],"prefix":"10.1007","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8348-1916","authenticated-orcid":false,"given":"Lisa","family":"Belter","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilse","family":"Peterson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jill","family":"Jarecki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,10,19]]},"reference":[{"issue":"2","key":"552_CR1","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1002\/mus.24497","volume":"51","author":"WD Arnold","year":"2015","unstructured":"Arnold WD, Kassar D, Kissel JT. Spinal muscular atrophy: diagnosis and management in a new therapeutic era. Muscle Nerve. 2015;51(2):157\u201367.","journal-title":"Muscle Nerve"},{"issue":"8","key":"552_CR2","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1001\/archneurol.2011.74","volume":"68","author":"SJ Kolb","year":"2011","unstructured":"Kolb SJ, Kissel JT. Spinal muscular atrophy: a timely review. Arch Neurol. 2011;68(8):979\u201384.","journal-title":"Arch Neurol"},{"issue":"4","key":"552_CR3","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1016\/j.ncl.2015.07.004","volume":"33","author":"SJ Kolb","year":"2015","unstructured":"Kolb SJ, Kissel JT. Spinal muscular atrophy. Neurol Clin. 2015;33(4):831\u201346.","journal-title":"Neurol Clin"},{"issue":"4","key":"552_CR4","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1007\/s00439-006-0156-7","volume":"119","author":"B Wirth","year":"2006","unstructured":"Wirth B, et al. Mildly affected patients with spinal muscular atrophy are partially protected by an increased SMN2 copy number. Hum Genet. 2006;119(4):422\u20138.","journal-title":"Hum Genet"},{"issue":"5","key":"552_CR5","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1001\/archneur.1995.00540290108025","volume":"52","author":"K Zerres","year":"1995","unstructured":"Zerres K, Rudnik-Schoneborn S. Natural history in proximal spinal muscular atrophy. Clinical analysis of 445 patients and suggestions for a modification of existing classifications. Arch Neurol. 1995;52(5):518\u201323.","journal-title":"Arch Neurol"},{"issue":"1","key":"552_CR6","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/S0022-510X(96)00284-5","volume":"146","author":"K Zerres","year":"1997","unstructured":"Zerres K, et al. A collaborative study on the natural history of childhood and juvenile onset proximal spinal muscular atrophy (type II and III SMA): 569 patients. J Neurol Sci. 1997;146(1):67\u201372.","journal-title":"J Neurol Sci"},{"issue":"5","key":"552_CR7","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1086\/302369","volume":"64","author":"B Wirth","year":"1999","unstructured":"Wirth B, et al. Quantitative analysis of survival motor neuron copies: identification of subtle SMN1 mutations in patients with spinal muscular atrophy, genotype-phenotype correlation, and implications for genetic counseling. Am J Hum Genet. 1999;64(5):1340\u201356.","journal-title":"Am J Hum Genet"},{"issue":"8","key":"552_CR8","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1177\/0883073807305788","volume":"22","author":"CH Wang","year":"2007","unstructured":"Wang CH, et al. Consensus statement for standard of care in spinal muscular atrophy. J Child Neurol. 2007;22(8):1027\u201349.","journal-title":"J Child Neurol"},{"issue":"2","key":"552_CR9","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1007\/s13311-014-0314-x","volume":"12","author":"MA Farrar","year":"2015","unstructured":"Farrar MA, Kiernan MC. The genetics of spinal muscular atrophy: progress and challenges. Neurotherapeutics. 2015;12(2):290\u2013302.","journal-title":"Neurotherapeutics"},{"issue":"4","key":"552_CR10","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1136\/jnnp-2016-314292","volume":"88","author":"RI Wadman","year":"2017","unstructured":"Wadman RI, et al. Association of motor milestones, SMN2 copy and outcome in spinal muscular atrophy types 0\u20134. J Neurol Neurosurg Psychiatry. 2017;88(4):365\u20137.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"9","key":"552_CR11","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1212\/WNL.0000000000000741","volume":"83","author":"RS Finkel","year":"2014","unstructured":"Finkel RS, et al. Observational study of spinal muscular atrophy type I and implications for clinical trials. Neurology. 2014;83(9):810\u20137.","journal-title":"Neurology"},{"issue":"1","key":"552_CR12","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1186\/s13023-017-0671-8","volume":"12","author":"IEC Verhaart","year":"2017","unstructured":"Verhaart IEC, et al. Prevalence, incidence and carrier frequency of 5q-linked spinal muscular atrophy\u2014a literature review. Orphanet J Rare Dis. 2017;12(1):124.","journal-title":"Orphanet J Rare Dis"},{"issue":"9630","key":"552_CR13","doi-asserted-by":"publisher","first-page":"2120","DOI":"10.1016\/S0140-6736(08)60921-6","volume":"371","author":"MR Lunn","year":"2008","unstructured":"Lunn MR, Wang CH. Spinal muscular atrophy. Lancet. 2008;371(9630):2120\u201333.","journal-title":"Lancet"},{"issue":"7","key":"552_CR14","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1007\/s00415-017-8549-1","volume":"264","author":"IEC Verhaart","year":"2017","unstructured":"Verhaart IEC, et al. A multi-source approach to determine SMA incidence and research ready population. J Neurol. 2017;264(7):1465\u201373.","journal-title":"J Neurol"},{"issue":"6","key":"552_CR15","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s11940-019-0568-z","volume":"21","author":"MA Waldrop","year":"2019","unstructured":"Waldrop MA, Kolb SJ. Current treatment options in neurology-SMA therapeutics. Curr Treat Options Neurol. 2019;21(6):25.","journal-title":"Curr Treat Options Neurol"},{"issue":"11","key":"552_CR16","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1007\/s40265-019-01162-5","volume":"79","author":"SM Hoy","year":"2019","unstructured":"Hoy SM. Onasemnogene abeparvovec: first global approval. Drugs. 2019;79(11):1255\u201362.","journal-title":"Drugs"},{"key":"552_CR17","volume-title":"Beyond health care: the role of social determinants in promoting health and health equity","author":"SHE Artiga","year":"2018","unstructured":"Artiga SHE. Beyond health care: the role of social determinants in promoting health and health equity. Kaiser Family Foundation; 2018."},{"issue":"18","key":"552_CR18","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1056\/NEJMoa1702752","volume":"377","author":"RS Finkel","year":"2017","unstructured":"Finkel RS, et al. Nusinersen versus sham control in infantile-onset spinal muscular atrophy. N Engl J Med. 2017;377(18):1723\u201332.","journal-title":"N Engl J Med"},{"issue":"1","key":"552_CR19","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s13023-019-1052-2","volume":"14","author":"HWY Wan","year":"2019","unstructured":"Wan HWY, et al. \u201cGetting ready for the adult world\u201d: how adults with spinal muscular atrophy perceive and experience healthcare, transition and well-being. Orphanet J Rare Dis. 2019;14(1):74.","journal-title":"Orphanet J Rare Dis"},{"issue":"9","key":"552_CR20","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1007\/s00415-008-0929-0","volume":"255","author":"S Piepers","year":"2008","unstructured":"Piepers S, et al. A natural history study of late onset spinal muscular atrophy types 3b and 4. J Neurol. 2008;255(9):1400\u20134.","journal-title":"J Neurol"},{"issue":"4","key":"552_CR21","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1080\/16501970510030156","volume":"37","author":"IJ de Groot","year":"2005","unstructured":"de Groot IJ, de Witte LP. Physical complaints in ageing persons with spinal muscular atrophy. J Rehabil Med. 2005;37(4):258\u201362.","journal-title":"J Rehabil Med"},{"issue":"1","key":"552_CR22","doi-asserted-by":"publisher","first-page":"109","DOI":"10.3233\/JND-180342","volume":"6","author":"S Dunaway Young","year":"2019","unstructured":"Dunaway Young S, et al. Perceived fatigue in spinal muscular atrophy: a pilot study. J Neuromuscul Dis. 2019;6(1):109\u201317.","journal-title":"J Neuromuscul Dis"},{"issue":"10","key":"552_CR23","doi-asserted-by":"publisher","first-page":"3458","DOI":"10.3390\/jcm12103458","volume":"12","author":"RS Rodriguez-Torres","year":"2023","unstructured":"Rodriguez-Torres RS, et al. Measuring fatigue and fatigability in spinal muscular atrophy (SMA): challenges and opportunities. J Clin Med. 2023;12(10):3458.","journal-title":"J Clin Med"},{"issue":"4","key":"552_CR24","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1212\/WNL.0b013e31827f07be","volume":"80","author":"BM Kluger","year":"2013","unstructured":"Kluger BM, Krupp LB, Enoka RM. Fatigue and fatigability in neurologic illnesses: proposal for a unified taxonomy. Neurology. 2013;80(4):409\u201316.","journal-title":"Neurology"},{"issue":"6","key":"552_CR25","doi-asserted-by":"publisher","first-page":"e845","DOI":"10.1212\/WNL.0000000000011230","volume":"96","author":"B Bartels","year":"2021","unstructured":"Bartels B, et al. Correlates of fatigability in patients with spinal muscular atrophy. Neurology. 2021;96(6):e845\u201352.","journal-title":"Neurology"},{"key":"552_CR26","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1002\/mus.27765","volume":"68","author":"R Cheng","year":"2022","unstructured":"Cheng R, et al. Perceived exertion is not a substitute for fatiguability in spinal muscular atrophy. Muscle Nerve. 2023;68(1):81\u201384.","journal-title":"Muscle Nerve"},{"issue":"12","key":"552_CR27","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1212\/WNL.0b013e3181f00304","volume":"75","author":"W King","year":"2010","unstructured":"King W, et al. Six-minute walk test demonstrates motor fatigue in spinal muscular atrophy. Neurology. 2010;75(12):1121\u20132 (author reply 1122).","journal-title":"Neurology"},{"issue":"6","key":"552_CR28","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1097\/00019052-199612000-00011","volume":"9","author":"LB Krupp","year":"1996","unstructured":"Krupp LB, Pollina DA. Mechanisms and management of fatigue in progressive neurological disorders. Curr Opin Neurol. 1996;9(6):456\u201360.","journal-title":"Curr Opin Neurol"},{"issue":"9","key":"552_CR29","doi-asserted-by":"publisher","first-page":"1893","DOI":"10.1016\/j.clinph.2012.12.053","volume":"124","author":"Y Noto","year":"2013","unstructured":"Noto Y, et al. Prominent fatigue in spinal muscular atrophy and spinal and bulbar muscular atrophy: evidence of activity-dependent conduction block. Clin Neurophysiol. 2013;124(9):1893\u20138.","journal-title":"Clin Neurophysiol"},{"issue":"3","key":"552_CR30","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1002\/acn3.51520","volume":"9","author":"C Binz","year":"2022","unstructured":"Binz C, et al. Validity and reliability of the German multidimensional fatigue inventory in spinal muscular atrophy. Ann Clin Transl Neurol. 2022;9(3):351\u201362.","journal-title":"Ann Clin Transl Neurol"},{"issue":"1","key":"552_CR31","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/s40120-022-00411-2","volume":"12","author":"JF Vazquez-Costa","year":"2023","unstructured":"Vazquez-Costa JF, et al. Validation of a set of instruments to assess patient- and caregiver-oriented measurements in spinal muscular atrophy: results of the SMA-TOOL study. Neurol Ther. 2023;12(1):89\u2013105.","journal-title":"Neurol Ther"},{"issue":"2","key":"552_CR32","doi-asserted-by":"publisher","first-page":"167","DOI":"10.3233\/JND-170292","volume":"5","author":"L Belter","year":"2018","unstructured":"Belter L, et al. An overview of the Cure SMA membership database: Highlights of key demographic and clinical characteristics of SMA members. J Neuromusc Dis. 2018;5(2):167\u201376.","journal-title":"J Neuromusc Dis"},{"issue":"1","key":"552_CR33","doi-asserted-by":"publisher","first-page":"15","DOI":"10.7224\/1537-2073.2012-019","volume":"15","author":"RD Larson","year":"2013","unstructured":"Larson RD. Psychometric properties of the Modified Fatigue Impact Scale. Int J MS Care. 2013;15(1):15\u201320.","journal-title":"Int J MS Care"},{"key":"552_CR34","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/1478-7954-7-18","volume":"7","author":"JM Lin","year":"2009","unstructured":"Lin JM, et al. Further validation of the Multidimensional Fatigue Inventory in a US adult population sample. Popul Health Metr. 2009;7:18.","journal-title":"Popul Health Metr"},{"issue":"1","key":"552_CR35","doi-asserted-by":"publisher","first-page":"34","DOI":"10.3109\/17477160903111706","volume":"5","author":"JW Varni","year":"2010","unstructured":"Varni JW, et al. The PedsQL multidimensional fatigue scale in pediatric obesity: feasibility, reliability and validity. Int J Pediatr Obes. 2010;5(1):34\u201342.","journal-title":"Int J Pediatr Obes"},{"issue":"5","key":"552_CR36","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1007\/s11136-013-0565-8","volume":"23","author":"U Werlauff","year":"2014","unstructured":"Werlauff U, et al. Fatigue in patients with spinal muscular atrophy type II and congenital myopathies: evaluation of the fatigue severity scale. Qual Life Res. 2014;23(5):1479\u201388.","journal-title":"Qual Life Res"},{"key":"552_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2020.102576","volume":"46","author":"LB Strober","year":"2020","unstructured":"Strober LB, et al. Tired of not knowing what that fatigue score means? Normative data of the Modified Fatigue Impact Scale (MFIS). Mult Scler Relat Disord. 2020;46: 102576.","journal-title":"Mult Scler Relat Disord"},{"issue":"10 Supplement","key":"552_CR38","doi-asserted-by":"crossref","first-page":"P7.117","DOI":"10.1212\/WNL.82.10_supplement.P7.117","volume":"82","author":"S Dunaway","year":"2014","unstructured":"Dunaway S, et al. Perceived fatigue and physiological fatigue in spinal muscular atrophy (SMA): are they related? (P7117). Neurology. 2014;82(10 Supplement):P7.117.","journal-title":"Neurology"},{"issue":"1","key":"552_CR39","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1007\/s11136-007-9282-5","volume":"17","author":"JW Varni","year":"2008","unstructured":"Varni JW, Limbers CA. The PedsQL\u2122 Multidimensional Fatigue Scale in young adults: feasibility, reliability and validity in a University student population. Qual Life Res. 2008;17(1):105\u201314.","journal-title":"Qual Life Res"},{"issue":"6","key":"552_CR40","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1002\/mus.27223","volume":"63","author":"CE Zizzi","year":"2021","unstructured":"Zizzi CE, et al. The Spinal Muscular Atrophy Health Index: a novel outcome for measuring how a patient feels and functions. Muscle Nerve. 2021;63(6):837\u201344.","journal-title":"Muscle Nerve"},{"issue":"3","key":"552_CR41","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1007\/s00415-020-10227-5","volume":"268","author":"C Binz","year":"2021","unstructured":"Binz C, et al. An observational cohort study on impact, dimensions and outcome of perceived fatigue in adult 5q-spinal muscular atrophy patients receiving nusinersen treatment. J Neurol. 2021;268(3):950\u201362.","journal-title":"J Neurol"}],"container-title":["Neurology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40120-023-00552-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40120-023-00552-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40120-023-00552-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,24]],"date-time":"2023-12-24T07:26:04Z","timestamp":1703402764000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40120-023-00552-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,19]]},"references-count":41,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["552"],"URL":"https:\/\/doi.org\/10.1007\/s40120-023-00552-y","relation":{},"ISSN":["2193-8253","2193-6536"],"issn-type":[{"value":"2193-8253","type":"print"},{"value":"2193-6536","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,19]]},"assertion":[{"value":"5 June 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 September 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 October 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Jill Jarecki is currently an employee of BioMarin Pharmaceuticals and was an employee of Cure SMA at the time of this study. Lisa Belter and Ilse Peterson declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"Institutional review board (IRB) approval was obtained from Western IRB on November 24, 2020 (IRB ID: 20203852). Consent was assumed from a respondent\u2019s survey participation. The study was performed in accordance with the Helsinki Declaration of 1964.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}